Source: FierceBiotechIT

JSB Partners: Israel's troubled Bioblast seeks partners, merger

Several months after abandoning plans for a securities offering, Israel's Bioblast Pharma has asked JSB-Partners to help it seek out a partner/merger to help lift it out of its troubles.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Wolfgang Stoiber's photo - Managing Partner of JSB Partners

Managing Partner

Wolfgang Stoiber

CEO Approval Rating

70/100

Read more